Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Exercise/Conversion of 39,265 TRAX shares, $225.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Exercise/Conversion | 39,265 | $225.4K |
| Jun 17, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Exercise/Conversion | 6,030 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 15,000 | n/a |
| Apr 22, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 28,571 | n/a |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 5,500 | n/a |
| Dec 23, 2025 | ANAPTYSBIO, INC (ANAB) | Sale | 3,900 | $193.3K |
| Jun 17, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 6,030 | n/a |
| Jan 7, 2025 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 16,510 | n/a |
| Jun 19, 2024 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 3,900 | n/a |
| Jan 5, 2024 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 16,510 | n/a |